Viscosupplementation Market
Market Insights on Viscosupplementation covering sales outlook, demand forecast & up-to-date key trends
Viscosupplementation Market By Product, Application, End User & Region - Forecast 2022 - 2030
Viscosupplementation Market Outlook (2022-2030)
[250 Pages] Worldwide viscosupplementation equipment sales are set to be valued at US$ 1.98 Bn in 2022. Detailed industry analysis reveals that the global viscosupplementation market is predicted to expand at a CAGR of 4.8% to reach a market valuation of US$ 2.89 Bn by 2030.
|
Viscosupplementation Market Size (2022) |
US$ 1.98 Bn |
|
Revenue Forecast (2030) |
US$ 2.89 Bn |
|
Global Market Growth Rate (2022-2030) |
4.8% CAGR |
|
Market Share of Three Injection Viscosupplementation |
53.9% |
Viscosupplementation treatment currently accounts for 23.9% share in the global osteoarthritis treatment market. The viscosupplementation market is predicted to rise steadily going forward mainly due to the increasing senior population across the world.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
4.61% |
|
H1, 2022 Projected |
4.84% |
|
H1, 2022 Outlook |
4.24% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 60 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 37 ↓ |
H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 60 BPS. In H1-2022, the growth rate of the viscosupplementation market is expected to fall by 37 basis point share (BPS), as per FMI analysis.
The market observes a decline in the BPS values due to the high costs associated with unit vials of viscosupplementation injectable, and the associated lower procedural adoption rates than expected, among the lower and middle income population groups.
Conversely, with the development of novel viscoelastic hydrogels to improve treatment outcomes, the market growth during the forecast years is set to witness a boost. Moreover, hyaluronic acid-based viscosupplementation therapy has now become established as a valid therapeutic approach for knee osteoarthritis and presents lucrative opportunities for market expansion over the coming years.
The key developments in the market include the launch of existing therapies, such as HyLink®, an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis in emerging economies such as Taiwan, as indicated by the recent press release by the company Seikagaku Corporation (August 2021).
The market is subject to changes as per the regulatory approvals and product launch activities with respect to the macroeconomic factors and industry dynamics.
Viscosupplementation Demand Analysis (2015 to 2021) Vs Market Outlook (2022 to 2030)
The viscosupplementation market expanded at a CAGR of 4.2% from 2015 to 2021. Viscosupplementation is a non-surgical, safe treatment for osteoarthritis of the knee. It is FDA approved and is more effective in treating people with early arthritis than it is in treating those with advanced arthritis.
A gel-like substance (hyaluronic acid) is pumped into the kneecap during viscosupplementation. The naturally occurring chemical hyaluronic acid is found in the synovial fluid that surrounds joints. It greases joints so that bones can move freely and discomfort is reduced. People with osteoarthritis have reduced levels of hyaluronic acid in their joints, which causes pain.
The injected gel acts as a cushion and greases up the joints, it is generated in biological research labs. Hyaluronic acid binds to a variety of proteins, allowing it to make ligaments resistant to pressure.
Adoption of innovative and good mix products, as well as an increase in the number of patients suffering from osteoarthritis, is influencing the market growth. The viscosupplementation market is predicted to progress at a steady CAGR of 4.8% from 2022 to 2030, with the global market expected to close in on a valuation of US$ 2.89 Bn by 2030.
Which Factors are Responsible for Driving Sales of Viscosupplementation Equipment?
“Growing Cases of Osteoarthritis & High Investments in R&D Fuelling Demand for Viscosupplementation Equipment”
Viscosupplementation device manufacturing companies are rushing to develop and approve new medicines to treat osteoarthritis in the elbow, hip, and knee. Viscosupplementation for knee osteoarthritis, followed by hip osteoarthritis, is likely to be a major growth driver. The main rationale is that viscosupplementation eliminates the need for knee replacement.
These days, anti-inflammatory medicines come with viscosupplementation. Furthermore, in some countries, such as France, 65 percent of the costs of 12 of the 13 medications capable of treating knee osteoarthritis are covered.
Medicare reimburses 80% of the patient-allowable cost in the United States. In the predicted period, these variables are likely to promote market growth. The growing demand for viscosupplementation devices has prompted manufacturers to focus their efforts on developing and marketing new viscosupplementation solutions.
Furthermore, the growing senior population across the globe would accelerate the market growth over the projected period, as the elderly are more susceptible to musculoskeletal illnesses such as osteoarthritis.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhy Are Ambulatory Surgical Centers Gaining Traction in This Market?
“Cost-effectiveness & Less Stay Time Make Ambulatory Surgical Centers Popular Choice for Treatment”
In the projected future, rise of ASCs (Ambulatory Surgical Centers) is expected to boost the viscosupplementation treatment market. ASCs offer benefits such as shorter stays and lower costs.
An ambulatory surgical center is a facility; either within or outside of a hospital that delivers diagnostic testing, treatment or even both to ambulatory patients in need of clinical, surgical, or mental care under the supervision of a licenced physician.
With the shift to value-based care in recent years, outpatient service locations, particularly those that offer physician office-based treatments and ambulatory surgery, have become fierce competitors for hospitals and healthcare systems. Outpatient facilities are gaining in popularity around the world because they provide both operational and financial advantages, allowing for easier patient access, more competitive pricing, and more chances for physician involvement.
As a result of all of the aforementioned factors, the viscosupplementation systems and solutions market is predicted to grow steadily in the future.
Which Regions are Most Lucrative for Viscosupplementation Equipment Manufacturers?
“Low Production Cost Attracts Manufacturers to Asia Pacific”
North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa are among the regions included in this viscosupplementation market report.
Due to rising healthcare expenditures, the Asia Pacific market is expected to grow rapidly during the forecast period. Furthermore, the low cost of manufacturing in China and India has led to an increase in production facilities, bringing pharmaceutical and biotechnology companies from all over the world to the Asia Pacific region. During the projected period, a rise in the prevalence of rheumatoid arthritis disorder is expected to drive market expansion in the region.
In North America, the market is being driven by a growing preference for short therapeutic interventions, despite their high cost, and a rising prevalence of illnesses such as osteoarthritis. The viscosupplementation market in Europe is also expected to increase dramatically in the future, owing to product innovation.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Country-wise Analysis
What is the Outlook for Viscosupplementation Treatment in Russia?
“Increasing Cases of Obesity & Growing Senior Population Boost Sales of Single Injection Viscosupplementation”
Rising obesity prevalence in Russia, combined with a rapidly growing geriatric population, is leading to an increase in knee osteoarthritis instances. In the Russia viscosupplementation market, this reason is driving the expansion of the single injection viscosupplementation segment.
Another reason driving rapid growth in Russia's viscosupplementation industry is the country's ageing population. The prevalence of osteoarthritis in Russia's adult population is estimated to be around 13%.
Rise in the popularity of three injection viscosupplementation is due to the fact that knee osteoarthritis is generating disability in Russia's ageing population. Three injection viscosupplementation is a cost-effective therapy that helps people with osteoarthritis of the knee save money.
How is Demand for Viscosupplementation Equipment Shaping Up in the U.S.?
“Advanced Healthcare Infrastructure Aiding Consumption of Viscosupplementation Equipment”
The market for viscosupplementation in the United States has continuously demonstrated strong yearly growth rates, and it is likely to expand at a healthy CAGR over the forecast period.
A single injection viscosupplementation is expected to produce the most constant growth, as it is more convenient than its three and five injection viscosupplementation. Furthermore, a growing geriatric population and improved healthcare infrastructure are driving market expansion.
Category-wise Analysis
Which Product Type is Responsible for Increasing Revenue Growth of the Viscosupplementation Market?
“Three Injection Viscosupplementation Prominent Viscosupplementation Treatment Procedure”
In the global viscosupplementation market, three injection viscosupplementation product type is expected to account for 53.9% of the market share in 2022. Over the next few years, three injection viscosupplementation is anticipated to be the most popular treatment for osteoarthritis.
The three and five injection hyaluronic acid viscosupplements have been around for a while, but the single injection products are newer. In 2022, single injection viscosupplementation is likely to account for 30.6% of the global market share. Due to a shorter regimen, fewer hospital appointments, and fewer adverse effects and associated pain, sales of single injection solutions are predicted to increase during the projection period.
For the past two decades, multiple three injections have indeed been accessible and have gained a considerable share of the global market. Medical professionals recommend three injections to help patients avoid total surgical intervention if they have osteoarthritis. At present five injection viscosupplementation is predicted to hold 13.6% of the global market share.
Competitive Landscape
Leading viscosupplementation equipment manufacturing companies are focusing on producing cross-linked hyaluronic acid to help with pain alleviation right away. They are making significant investments to get a competitive advantage over one another.
The viscosupplementation treatment industry is seeing the introduction of new products as well as its development into new geographies.
- Anika Therapeutics' proprietary medicine "CINGAL" has seen positive Phase III trial results.
- Sanofi S.A.'s "Synvisc-one" viscosupplement appears to be an exclusive blend of two cross-linked polymers incorporating hyaluronic acid formulations. Synvisc-makeup ones allow it to function as both, a fluid and gel. Long-term therapeutic efficacy is said to be enhanced by the high molecular weight.
Viscosupplementation Industry Report Scope
|
Attribute |
Details |
|
Forecast Period |
2022-2030 |
|
Historical Data Available for |
2015-2021 |
|
Market Analysis |
US$ Bn for Value |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Segments of Viscosupplementation Industry Survey
Viscosupplementation Market by Product:
- Single Injection Viscosupplementation
- Three Injection Viscosupplementation
- Five Injection Viscosupplementation
Viscosupplementation Market by Application:
- Knee Osteoarthritis
- Hip Osteoarthritis
- Shoulder Osteoarthritis
- Others
Viscosupplementation Market by End User:
- Hospitals
- Ambulatory Surgical Centers
- Orthopedic Clinics
- Retail Pharmacies
- Online Sales
Viscosupplementation Market by Region:
- North America Viscosupplementation Market
- Latin America Viscosupplementation Market
- Europe Viscosupplementation Market
- East Asia Viscosupplementation Market
- South Asia & Pacific Viscosupplementation Market
- Middle East & Africa (MEA) Viscosupplementation Market
Frequently Asked Questions
Three injection viscosupplementation is a lucrative segment among the product types in the viscosupplementation market.
The global viscosupplementation market is estimated to expand at a CAGR of 4.8% through 2030.
The global viscosupplementation market is currently valued at around US$ 1.98 Bn, and is predicted to reach US$ 2.89 Bn by 2030.
Key viscosupplementation device manufacturers are Sanofi S.A. (France), Zimmer Biomet Holdings Inc. (U. S.), Bioventus LLC (U. S.), Anika Therapeutics Inc. (U. S.), Fidia Farmaceutici S.p.A. (Italy), Ferring B.V. (Switzerland), Seikagaku Corporation (Japan), Chugai Pharmaceutical Co., Ltd. (Japan), OrthogenRx Inc. (U. S.), and Mylan N.V. (U. S.).
The Asia Pacific viscosupplementation market is predicted to expand rapidly from 2022 to 2030.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Background
4.1. COVID19 Crisis Analysis
4.1.1. Current COVID19 Statistics and Probable Future Impact
4.1.2. Current GDP Projection and Probable Impact
4.1.3. Current Economic Projection as compared to 2008 Economic analysis
4.1.4. COVID19 and Impact Analysis
4.1.4.1. Revenue By Product Type
4.1.4.2. Revenue By Application
4.1.4.3. Revenue By Country
4.1.5. 2022 Market Scenario
4.1.6. Quarter by Quarter Forecast
4.1.7. Projected recovery Quarter
4.1.8. Recovery Scenario – Short term, Midterm and Long Term Impact
4.2. Macro-Economic Factors
4.2.1. Global GDP Growth Outlook
4.2.2. Global Healthcare Outlook
4.3. Forecast Factors - Relevance & Impact
4.3.1. Historical Growth of Top Players
4.3.2. New Product Approval and Launch
4.3.3. Adoption of Viscosupplementation
4.3.4. Cost of Viscosupplementation
4.3.5. Increasing Epidemic of Viscosuppplementation Infections
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
5. Market Context
5.1. Product USPs/ Features
5.2. Epidemiological of Osteoarthritis
5.3. Pipeline Assessment
5.4. New Product Approvals
5.5. Clinical Trial Assessment
5.6. Product Adoption / Application Analysis
5.7. Regulatory Scenario
6. Global Market Value (US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Opportunity Analysis, 2022-2030
7. Global Market Analysis 2015-2021 and Forecast 2022-2030, By Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2015–2021
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2022-2030
7.3.1. Single Injection Viscosuppplementation
7.3.2. Three Injection Viscosupplementation
7.3.3. Five Injection Viscosupplementation
7.4. Market Attractiveness Analysis By Product Type
8. Global Market Analysis 2015-2021 and Forecast 2022-2030, By Application
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Application, 2015–2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2030
8.3.1. Knee Osteoarthritis
8.3.2. Hip Osteoarthritis
8.3.3. Shoulder Osteoarthritis
8.3.4. Others
8.4. Market Attractiveness Analysis By Application
9. Global Market Analysis 2015-2021 and Forecast 2022-2030, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2030
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Orthopaedic Clinics
9.3.4. Retail Pharmacies
9.3.5. Online Sales
9.4. Market Attractiveness Analysis By End User
10. Global Market Analysis 2015-2021 and Forecast 2022-2030, by Region
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2030
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia Pacific
10.3.6. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2015-2021 and Forecast 2022-2030
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Product Type
11.3.3. By Application
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.5. Key Market Participants - Intensity Mapping
11.6. Drivers and Restraints - Impact Analysis
12. Latin America Market Analysis 2015-2021 and Forecast 2022-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Product Type
12.3.3. By Application
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
13. Europe Market Analysis 2015-2021 and Forecast 2022-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Product Type
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. South Asia and Oceania Market Analysis 2015-2021 and Forecast 2022-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
14.3.1. By Country
14.3.1.1. India
14.3.1.2. ASEAN
14.3.1.3. Australia
14.3.1.4. New Zealand
14.3.2. By Product Type
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. East Asia Market Analysis 2015-2021 and Forecast 2022-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product Type
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
16.3.1. By Country
16.3.1.1. GCC Countries
16.3.1.2. Turkey
16.3.1.3. South Africa
16.3.1.4. Rest of Middle East and Africa
16.3.2. By Product Type
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Emerging Countries Market Analysis 2015-2021 and Forecast 2022-2030
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. China Market Analysis
17.2.1. By Product Type
17.2.2. By Application
17.2.3. By End User
17.3. India Market Analysis
17.3.1. By Product Type
17.3.2. By Application
17.3.3. By End User
17.4. Brazil Market Analysis
17.4.1. By Product Type
17.4.2. By Application
17.4.3. By End User
18. Key Countries Market Analysis 2015-2021 and Forecast 2022-2030
18.1. U.S. Market Analysis
18.1.1. By Product Type
18.1.2. By Application
18.1.3. By End User
18.2. Canada Market Analysis
18.2.1. By Product Type
18.2.2. By Application
18.2.3. By End User
18.3. Mexico Market Analysis
18.3.1. By Product Type
18.3.2. By Application
18.3.3. By End User
18.4. U.K. Market Analysis
18.4.1. By Product Type
18.4.2. By Application
18.4.3. By End User
18.5. Germany Market Analysis
18.5.1. By Product Type
18.5.2. By Application
18.5.3. By End User
18.6. France Market Analysis
18.6.1. By Product Type
18.6.2. By Application
18.6.3. By End User
18.7. Italy Market Analysis
18.7.1. By Product Type
18.7.2. By Application
18.7.3. By End User
18.8. Spain Market Analysis
18.8.1. By Product Type
18.8.2. By Application
18.8.3. By End User
18.9. BENELUX Market Analysis
18.9.1. By Product Type
18.9.2. By Application
18.9.3. By End User
18.10. Russia Market Analysis
18.10.1. By Product Type
18.10.2. By Application
18.10.3. By End User
18.11. Japan Market Analysis
18.11.1. By Product Type
18.11.2. By Application
18.11.3. By End User
18.12. South Korea Market Analysis
18.12.1. By Product Type
18.12.2. By Application
18.12.3. By End User
18.13. ASEAN Market Analysis
18.13.1. By Product Type
18.13.2. By Application
18.13.3. By End User
18.14. Australia Market Analysis
18.14.1. By Product Type
18.14.2. By Application
18.14.3. By End User
18.15. New Zealand Market Analysis
18.15.1. By Product Type
18.15.2. By Application
18.15.3. By End User
18.16. GCC Countries Market Analysis
18.16.1. By Product Type
18.16.2. By Application
18.16.3. By End User
18.17. Turkey Market Analysis
18.17.1. By Product Type
18.17.2. By Application
18.17.3. By End User
18.18. South Africa Market Analysis
18.18.1. By Product Type
18.18.2. By Application
18.18.3. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
19.3.1. Regional Footprint by Players
19.3.2. Product Foot print by Players
19.3.3. Channel Foot Print by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Sanofi S.A.
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Profitability by Market Segments (Product/Channel/Region)
20.3.1.4. Sales Footprint
20.3.1.5. Strategy Overview
20.3.1.5.1. Marketing Strategy
20.3.1.5.2. Product Strategy
20.3.1.5.3. Channel Strategy
20.3.2. Zimmer Biomet Holdings Inc.
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Profitability by Market Segments (Product/Channel/Region)
20.3.2.4. Sales Footprint
20.3.2.5. Strategy Overview
20.3.2.5.1. Marketing Strategy
20.3.2.5.2. Product Strategy
20.3.2.5.3. Channel Strategy
20.3.3. Bioventus LLC
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Profitability by Market Segments (Product/Channel/Region)
20.3.3.4. Sales Footprint
20.3.3.5. Strategy Overview
20.3.3.5.1. Marketing Strategy
20.3.3.5.2. Product Strategy
20.3.3.5.3. Channel Strategy
20.3.4. Anika Therapeutics Inc.
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Profitability by Market Segments (Product/Channel/Region)
20.3.4.4. Sales Footprint
20.3.4.5. Strategy Overview
20.3.4.5.1. Marketing Strategy
20.3.4.5.2. Product Strategy
20.3.4.5.3. Channel Strategy
20.3.5. Fidia Farmaceutici S.p.A.
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Profitability by Market Segments (Product/Channel/Region)
20.3.5.4. Sales Footprint
20.3.5.5. Strategy Overview
20.3.5.5.1. Marketing Strategy
20.3.5.5.2. Product Strategy
20.3.5.5.3. Channel Strategy
20.3.6. Ferring B.V.
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Profitability by Market Segments (Product/Channel/Region)
20.3.6.4. Sales Footprint
20.3.6.5. Strategy Overview
20.3.6.5.1. Marketing Strategy
20.3.6.5.2. Product Strategy
20.3.6.5.3. Channel Strategy
20.3.7. Seikagaku Corporation
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Profitability by Market Segments (Product/Channel/Region)
20.3.7.4. Sales Footprint
20.3.7.5. Strategy Overview
20.3.7.5.1. Marketing Strategy
20.3.7.5.2. Product Strategy
20.3.7.5.3. Channel Strategy
20.3.8. Chungai Pharmaceutical Co., Ltd.
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Profitability by Market Segments (Product/Channel/Region)
20.3.8.4. Sales Footprint
20.3.8.5. Strategy Overview
20.3.8.5.1. Marketing Strategy
20.3.8.5.2. Product Strategy
20.3.8.5.3. Channel Strategy
20.3.9. OrthogenRx Inc.
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Profitability by Market Segments (Product/Channel/Region)
20.3.9.4. Sales Footprint
20.3.9.5. Strategy Overview
20.3.9.5.1. Marketing Strategy
20.3.9.5.2. Product Strategy
20.3.9.5.3. Channel Strategy
20.3.10. Mylan N.V
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Profitability by Market Segments (Product/Channel/Region)
20.3.10.4. Sales Footprint
20.3.10.5. Strategy Overview
20.3.10.5.1. Marketing Strategy
20.3.10.5.2. Product Strategy
20.3.10.5.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country
Table 06: North America Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product Type
Table 07: North America Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application
Table 08: North America Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User
Table 09: Latin America Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country
Table 10: Latin America Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product Type
Table 11: Latin America Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application
Table 12: Latin America Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User
Table 13: Europe Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country
Table 14: Europe Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product Type
Table 15: Europe Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application
Table 16: Europe Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User
Table 17: South Asia Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country
Table 18: South Asia Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product Type
Table 19: South Asia Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application
Table 20: South Asia Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User
Table 21: East Asia Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country
Table 22: East Asia Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product Type
Table 23: East Asia Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application
Table 24: East Asia Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User
Table 25: Oceania Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country
Table 26: Oceania Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product Type
Table 27: Oceania Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application
Table 28: Oceania Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User
Table 29: MEA Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country
Table 30: MEA Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product Type
Table 31: MEA Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application
Table 32: MEA Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User
Table 33: India Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product Type
Table 34: India Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application
Table 35: India Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User
Table 36: China Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product Type
Table 37: China Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application
Table 38: China Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User
Table 39: Brazil Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product Type
Table 40: Brazil Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application
Table 41: Brazil Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Value Analysis (US$ Mn), 2015-2021
Figure 02: Global Market Value Forecast (US$ Mn), 2022-2030
Figure 03: Global Market Absolute $ Opportunity, 2022 - 2030
Figure 04: Global Market Share Analysis (%), By Product Type, 2022-2030
Figure 05: Global Market Y-o-Y Analysis (%), By Product Type, 2022-2030
Figure 06: Global Market Attractiveness Analysis by Product Type, 2022-2030
Figure 07: Global Market Share Analysis (%), By Application, 2022-2030
Figure 08: Global Market Y-o-Y Analysis (%), By Application, 2022-2030
Figure 09: Global Market Attractiveness Analysis by Application, 2022-2030
Figure 10: Global Market Share Analysis (%), By End User, 2022-2030
Figure 11: Global Market Y-o-Y Analysis (%), By End User, 2022-2030
Figure 12: Global Market Attractiveness Analysis by End User, 2022-2030
Figure 13: Global Market Share Analysis (%), By Region, 2022-2030
Figure 14: Global Market Y-o-Y Analysis (%), By Region, 2022-2030
Figure 15: Global Market Attractiveness Analysis by Region, 2022-2030
Figure 16: North America Market Value Share, By Product Type, 2022 (E)
Figure 17: North America Market Value Share, By Application, 2022 (E)
Figure 18: North America Market Value Share, By End User, 2022 (E)
Figure 19: North America Market Value Share, By Country, 2022 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2015-2021
Figure 21: North America Market Value Forecast (US$ Mn), 2022-2030
Figure 22: North America Market Attractiveness Analysis by Product Type, 2022-2030
Figure 23: North America Market Attractiveness Analysis by Application, 2022-2030
Figure 24: North America Market Attractiveness Analysis by End Users, 2022-2030
Figure 25: North America Market Attractiveness Analysis by Country, 2022-2030
Figure 26: Latin America Market Value Share, By Product Type, 2022 (E)
Figure 27: Latin America Market Value Share, By Application, 2022 (E)
Figure 28: Latin America Market Value Share, By End User, 2022 (E)
Figure 29: Latin America Market Value Share, By Country, 2022 (E)
Figure 30: Latin America Market Value Analysis (US$ Mn), 2015-2021
Figure 31: Latin America Market Value Forecast (US$ Mn), 2022-2030
Figure 32: Latin America Market Attractiveness Analysis by Product Type, 2022-2030
Figure 33: Latin America Market Attractiveness Analysis by Application, 2022-2030
Figure 34: Latin America Market Attractiveness Analysis by End Users, 2022-2030
Figure 35: Latin America Market Attractiveness Analysis by Country, 2022-2030
Figure 36: Europe Market Value Share, By Product Type, 2022 (E)
Figure 37: Europe Market Value Share, By Application, 2022 (E)
Figure 38: Europe Market Value Share, By End User, 2022 (E)
Figure 39: Europe Market Value Share, By Country, 2022 (E)
Figure 40: Europe Market Value Analysis (US$ Mn), 2015-2021
Figure 41: Europe Market Value Forecast (US$ Mn), 2022-2030
Figure 42: Europe Market Attractiveness Analysis by Product Type, 2022-2030
Figure 43: Europe Market Attractiveness Analysis by Application, 2022-2030
Figure 44: Europe Market Attractiveness Analysis by End Users, 2022-2030
Figure 45: Europe Market Attractiveness Analysis by Country, 2022-2030
Figure 46: South Asia Market Value Share, By Product Type, 2022 (E)
Figure 47: South Asia Market Value Share, By Application, 2022 (E)
Figure 48: South Asia Market Value Share, By End User, 2022 (E)
Figure 49: South Asia Market Value Share, By Country, 2022 (E)
Figure 50: South Asia Market Value Analysis (US$ Mn), 2015-2021
Figure 51: South Asia Market Value Forecast (US$ Mn), 2022-2030
Figure 52: South Asia Market Attractiveness Analysis by Product Type, 2022-2030
Figure 53: South Asia Market Attractiveness Analysis by Application, 2022-2030
Figure 54: South Asia Market Attractiveness Analysis by End Users, 2022-2030
Figure 55: South Asia Market Attractiveness Analysis by Country, 2022-2030
Figure 56: East Asia Market Value Share, By Product Type, 2022 (E)
Figure 57: East Asia Market Value Share, By Application, 2022 (E)
Figure 58: East Asia Market Value Share, By End User, 2022 (E)
Figure 59: East Asia Market Value Share, By Country, 2022 (E)
Figure 60: East Asia Market Value Analysis (US$ Mn), 2015-2021
Figure 61: East Asia Market Value Forecast (US$ Mn), 2022-2030
Figure 62: East Asia Market Attractiveness Analysis by Product Type, 2022-2030
Figure 63: East Asia Market Attractiveness Analysis by Application, 2022-2030
Figure 64: East Asia Market Attractiveness Analysis by End Users, 2022-2030
Figure 65: East Asia Market Attractiveness Analysis by Country, 2022-2030
Figure 66: Oceania Market Value Share, By Product Type, 2022 (E)
Figure 67: Oceania Market Value Share, By Application, 2022 (E)
Figure 68: Oceania Market Value Share, By End User, 2022 (E)
Figure 69: Oceania Market Value Share, By Country, 2022 (E)
Figure 70: Oceania Market Value Analysis (US$ Mn), 2015-2021
Figure 71: Oceania Market Value Forecast (US$ Mn), 2022-2030
Figure 72: Oceania Market Attractiveness Analysis by Product Type, 2022-2030
Figure 73: Oceania Market Attractiveness Analysis by Application, 2022-2030
Figure 74: Oceania Market Attractiveness Analysis by End Users, 2022-2030
Figure 75: Oceania Market Attractiveness Analysis by Country, 2022-2030
Figure 76: MEA Market Value Share, By Product Type, 2022 (E)
Figure 77: MEA Market Value Share, By Application, 2022 (E)
Figure 78: MEA Market Value Share, By End User, 2022 (E)
Figure 79: MEA Market Value Share, By Country, 2022 (E)
Figure 80: MEA Market Value Analysis (US$ Mn), 2015-2021
Figure 81: MEA Market Value Forecast (US$ Mn), 2022-2030
Figure 82: MEA Market Attractiveness Analysis by Product Type, 2022-2030
Figure 83: MEA Market Attractiveness Analysis by Application, 2022-2030
Figure 84: MEA Market Attractiveness Analysis by End Users, 2022-2030
Figure 85: MEA Market Attractiveness Analysis by Country, 2022-2030
Figure 86: India Market Value Analysis (US$ Mn), 2015-2021
Figure 87: India Market Value Forecast (US$ Mn), 2022-2030
Figure 88: China Market Value Analysis (US$ Mn), 2015-2021
Figure 89: China Market Value Forecast (US$ Mn), 2022-2030
Figure 90: Brazil Market Value Analysis (US$ Mn), 2015-2021
Figure 91: Brazil Market Value Forecast (US$ Mn), 2022-2030
Figure 92: U. S. Market Value Analysis (US$ Mn), 2022 & 2030
Figure 93: U. S. Market Value Share, By Product Type, 2022 (E)
Figure 94: U. S. Market Value Share, By Application, 2022 (E)
Figure 95: U. S. Market Value Share, By End User, 2022 (E)
Figure 96: Canada Market Value Analysis (US$ Mn), 2022 & 2030
Figure 97: Canada Market Value Share, By Product Type, 2022 (E)
Figure 98: Canada Market Value Share, By Application, 2022 (E)
Figure 99: Canada Market Value Share, By End User, 2022 (E)
Figure 100: Mexico Market Value Analysis (US$ Mn), 2022 & 2030
Figure 101: Mexico Market Value Share, By Product Type, 2022 (E)
Figure 102: Mexico Market Value Share, By Application, 2022 (E)
Figure 103: Mexico Market Value Share, By End User, 2022 (E)
Figure 104: Germany Market Value Analysis (US$ Mn), 2022 & 2030
Figure 105: Germany Market Value Share, By Product Type, 2022 (E)
Figure 106: Germany Market Value Share, By Application, 2022 (E)
Figure 107: Germany Market Value Share, By End User, 2022 (E)
Figure 108: U.K. Market Value Analysis (US$ Mn), 2022 & 2030
Figure 109: U.K. Market Value Share, By Product Type, 2022 (E)
Figure 110: U.K Market Value Share, By Application, 2022 (E)
Figure 111: U.K. Market Value Share, By End User, 2022 (E)
Figure 112: France Market Value Analysis (US$ Mn), 2022 & 2030
Figure 113: France Market Value Share, By Product Type, 2022 (E)
Figure 114: France Market Value Share, By Application, 2022 (E)
Figure 115: France Market Value Share, By End User, 2022 (E)
Figure 116: Italy Market Value Analysis (US$ Mn), 2022 & 2030
Figure 117: Italy Market Value Share, By Product Type, 2022 (E)
Figure 118: Italy Market Value Share, By Application, 2022 (E)
Figure 119: Italy Market Value Share, By End User, 2022 (E)
Figure 120: Spain Market Value Analysis (US$ Mn), 2022 & 2030
Figure 121: Spain Market Value Share, By Product Type, 2022 (E)
Figure 122: Spain Market Value Share, By Application, 2022 (E)
Figure 123: Spain Market Value Share, By End User, 2022 (E)
Figure 124: Russia Market Value Analysis (US$ Mn), 2022 & 2030
Figure 125: Russia Market Value Share, By Product Type, 2022 (E)
Figure 126: Russia Market Value Share, By Application, 2022 (E)
Figure 127: Russia Market Value Share, By End User, 2022 (E)
Figure 128: Japan Market Value Analysis (US$ Mn), 2022 & 2030
Figure 129: Japan Market Value Share, By Product Type, 2022 (E)
Figure 130: Japan Market Value Share, By Application, 2022 (E)
Figure 131: Japan Market Value Share, By End User, 2022 (E)
Figure 132: South Korea Market Value Analysis (US$ Mn), 2022 & 2030
Figure 133: South Korea Market Value Share, By Product Type, 2022 (E)
Figure 134: South Korea Market Value Share, By Application, 2022 (E)
Figure 135: South Korea Market Value Share, By End User, 2022 (E)
Figure 136: Australia Market Value Analysis (US$ Mn), 2022 & 2030
Figure 137: Australia Market Value Share, By Product Type, 2022 (E)
Figure 138: Australia Market Value Share, By Application, 2022 (E)
Figure 139: Australia Market Value Share, By End User, 2022 (E)
Figure 140: New Zealand Market Value Analysis (US$ Mn), 2022 & 2030
Figure 141: New Zealand Market Value Share, By Product Type, 2022 (E)
Figure 142: New Zealand Market Value Share, By Application, 2022 (E)
Figure 143: New Zealand Market Value Share, By End User, 2022 (E)
Figure 144: GCC Countries Market Value Analysis (US$ Mn), 2022 & 2030
Figure 145: GCC Countries Market Value Share, By Product Type, 2022 (E)
Figure 146: GCC Countries Market Value Share, By Application, 2022 (E)
Figure 147: GCC Countries Market Value Share, By End User, 2022 (E)
Figure 148: South Africa Market Value Analysis (US$ Mn), 2022 & 2030
Figure 149: South Africa Market Value Share, By Product Type, 2022 (E)
Figure 150: South Africa Market Value Share, By Application, 2022 (E)
Figure 151: South Africa Market Value Share, By End User, 2022 (E)
Figure 152: Turkey Market Value Analysis (US$ Mn), 2022 & 2030
Figure 153: Turkey Market Value Share, By Product Type, 2022 (E)
Figure 154: Turkey Market Value Share, By Application, 2022 (E)
Figure 155: Turkey Market Value Share, By End User, 2022 (E)
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
